Initial public offerings scheduled to debut next week
NEW YORK, N.Y. - The following is a list of initial public offerings planned for the coming week. Sources include Renaissance Capital, Greenwich, CT (www.renaissancecapital.com) and SEC filings.
Week of March 10:
Achaogen Inc. - South San Francisco, Calif., 5 million shares, priced $12 to $14, managed by Credit Suisse and Cowen & Co. Proposed Nasdaq symbol AKAO. Business: Developing antibiotic treatments of multi-drug resistant infections.
Castlight Health Inc. - San Francisco, 11.1 million shares, priced $9 to $11, managed by Goldman Sachs and Morgan Stanley. Proposed NYSE symbol CSLT. Business: Provides an on-demand software platform that helps self-insured employers control healthcare costs.
Diamond S Shipping Group Inc. - Greenwich, Conn., 14 million shares, priced $14 to $16, managed by Jefferies and BofA Merrill Lynch. Proposed NYSE symbol DSG. Business: Second-largest medium range oil tanker operator.
Dipexium Pharmaceuticals Inc. - New York, 2.3 million shares, priced $12 to $14, managed by Oppenheimer. Proposed Nasdaq symbol DPRX. Business: Late-stage biotech developing a topical antibiotic for diabetic foot ulcer infections.
Galmed Pharmaceuticals Ltd. - Tel Aviv, Israel, 2.35 million ordinary shares, priced $12 to $14, managed by Maxim Group. Proposed Nasdaq symbol GLMD. Business: Clinical-stage biotech developing therapies for liver diseases and gallstones.